Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.31%

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has an Asset Resilience Ratio of 0.31% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 301126 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥19.82 Million
≈ $2.90 Million USD Cash + Short-term Investments

Total Assets

CN¥6.39 Billion
≈ $935.45 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Hunan Dajiaweikang Pharmaceutical Indust total assets.

Liquid Assets Composition Over Time

This chart breaks down Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 301126 total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥19.82 Million 0.31%
Total Liquid Assets CN¥19.82 Million 0.31%

Asset Resilience Insights

  • Limited Liquidity: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd maintains only 0.31% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
Pharmaceutical Retailers 0.01%
Trxade Group Inc
NASDAQ:MEDS
Pharmaceutical Retailers 0.19%
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.46%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.00%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 2.05%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.02%
Yifeng Pharmacy
SHG:603939
Pharmaceutical Retailers 19.16%
Dashenlin Pharm Grp Co Ltd
SHG:603233
Pharmaceutical Retailers 0.80%

Annual Asset Resilience Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2022–2025)

The table below shows the annual Asset Resilience Ratio data for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.16% CN¥9.82 Million
≈ $1.44 Million
CN¥6.34 Billion
≈ $927.29 Million
-2.39pp
2022-12-31 2.54% CN¥100.00 Million
≈ $14.63 Million
CN¥3.93 Billion
≈ $575.29 Million
--
pp = percentage points

About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

SHE:301126 China Pharmaceutical Retailers
Market Cap
$307.78 Million
CN¥2.10 Billion CNY
Market Cap Rank
#14810 Global
#4429 in China
Share Price
CN¥10.24
Change (1 day)
+1.39%
52-Week Range
CN¥8.00 - CN¥14.35
All Time High
CN¥36.14
About

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more